Lv3
370 积分 2023-10-22 加入
Bismuth add-on improves the efficacy of 2-week tegoprazan-based triple therapy for first-line Helicobacter pylori eradication: a real-world evidence study
2小时前
待确认
Comparative efficacy of Helicobacter pylori eradication therapy between tegoprazan‐based concomitant and bismuth quadruple therapies: A real‐world evidence
4天前
已完结
Fourteen‐Day Tegoprazan–Amoxicillin Dual Therapy as the First‐Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial
7天前
已完结
Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China
9天前
已完结
Helicobacter pylori, gastric cancer and the screening conundrum
1个月前
已关闭
The Impact of Population-Based Helicobacter pylori Test-To-Treat Strategies on Gastric Cancer Outcomes
1个月前
已关闭
Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric Cancer
2个月前
已完结
<i>Streptococcus anginosus</i>: A new pathogen of superficial gastritis, atrophic gastritis and gastric cancer
2个月前
已完结
SimplifiedHelicobacter pyloritherapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy
5个月前
已完结
Comparison of the efficacy between the dual therapy of tegoprazan and the quadruple therapy of tegoprazan: A randomized, controlled, multicenter study
5个月前
已完结
皖公网安备34019202002308
